Co-Diagnostics Inc (CODX)

Co-Diagnostics Completes Clinical and Analytical Studies in Preparation for FDA 510(k) Submission of Upper Respiratory Point-of-Care Test

Co-Diagnostics Completes Clinical and Analytical Studies in Preparation for FDA 510(k) Submission of Upper...

Co-Diagnostics Vector Smart® Division Expands Footprint to 21 States

Co-Diagnostics Vector Smart® Division Expands Footprint to 21 States PR Newswire SALT LAKE CITY, June 25...

Co-Diagnostics Hosts Kingdom of Saudi Arabia Joint Venture CoMira for Unveiling of Future Automated Manufacturing Line

Co-Diagnostics Hosts Kingdom of Saudi Arabia Joint Venture CoMira for Unveiling of Future Automated...

Co-Diagnostics Advances Latin American Commercialization Strategy for Co-Dx™ PCR Pro® with Mexico Distributor Agreement

Co-Diagnostics Advances Latin American Commercialization Strategy for Co-Dx™ PCR Pro® with Mexico Distributor...

Co-Diagnostics and CoSara Advance Ebola PCR Test Development and Co-Dx™ PCR Point-of-Care Platform Capabilities

Co-Diagnostics and CoSara Advance Ebola PCR Test Development and Co-Dx™ PCR Point-of-Care Platform...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Co-Diagnostics Advances Ebola PCR Assay Development Strategy with Joint Venture CoSara

Co-Diagnostics Advances Ebola PCR Assay Development Strategy with Joint Venture CoSara PR Newswire SALT...

Form 8-K - Current report

Co-Diagnostics Announces $3.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Co-Diagnostics Announces $3.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules PR Newswire...

Diagnostic Platform Jumps as Ebola Response Readiness Takes Center Stage

Global public health systems have become increasingly focused on rapid diagnostic readiness since the COVID-19 pandemic exposed the risks of...

Co-Diagnostics Develops Ebola Assay Strategy Following WHO Emergency Alert (CODX)

The company said it is prepared to rapidly deploy a Bundibugyo virus Ebola test if outbreak conditions require expanded diagnostic response...